These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1110 related items for PubMed ID: 19558334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS.
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
    Henriet AC, Marchand-Adam S, Mankikian J, Diot P.
    Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D, de Backer W, Hamilton M, Cahn A, Preece A, Kelleher D, Baines A, Moore A, Brealey N, Moynihan J.
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [Abstract] [Full Text] [Related]

  • 8. Advances in chronic obstructive pulmonary disease.
    Barnes PJ.
    Trans Med Soc Lond; 2015 Dec; 119():41-51. PubMed ID: 17184031
    [Abstract] [Full Text] [Related]

  • 9. New treatments for chronic obstructive pulmonary disease.
    Barnes PJ.
    Ann Ist Super Sanita; 2003 Dec; 39(4):573-82. PubMed ID: 15098577
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO, Young PM, Rogueda P, Lallement A, Iliev I, Traini D.
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [Abstract] [Full Text] [Related]

  • 16. Frontrunners in novel pharmacotherapy of COPD.
    Barnes PJ.
    Curr Opin Pharmacol; 2008 Jun; 8(3):300-7. PubMed ID: 18457992
    [Abstract] [Full Text] [Related]

  • 17. Customizing inhaled therapy to meet the needs of COPD patients.
    Fromer L, Goodwin E, Walsh J.
    Postgrad Med; 2010 Mar; 122(2):83-93. PubMed ID: 20203459
    [Abstract] [Full Text] [Related]

  • 18. New treatments for COPD.
    Barnes PJ.
    Nat Rev Drug Discov; 2002 Jun; 1(6):437-46. PubMed ID: 12119745
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Emerging drugs for chronic obstructive pulmonary disease.
    Matera MG, Calzetta L, Segreti A, Cazzola M.
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):61-82. PubMed ID: 22335427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.